A detailed history of Titleist Asset Management, Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Titleist Asset Management, Ltd. holds 3,813 shares of NVO stock, worth $398,687. This represents 0.12% of its overall portfolio holdings.

Number of Shares
3,813
Previous 3,647 4.55%
Holding current value
$398,687
Previous $363,000 42.15%
% of portfolio
0.12%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

BUY
$102.55 - $135.33 $17,023 - $22,464
166 Added 4.55%
3,813 $0
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $21,819 - $26,776
-229 Reduced 5.91%
3,647 $363,000
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $27,978 - $33,010
271 Added 7.52%
3,876 $432,000
Q1 2022

May 04, 2022

BUY
$93.1 - $112.54 $47,853 - $57,845
514 Added 16.63%
3,605 $400,000
Q4 2021

Feb 17, 2022

BUY
$95.88 - $117.08 $296,365 - $361,894
3,091 New
3,091 $346,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Titleist Asset Management, Ltd. Portfolio

Follow Titleist Asset Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Titleist Asset Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Titleist Asset Management, Ltd. with notifications on news.